Objectives: Early detection of neuropsychiatric symptoms is critical for timely intervention in cognitive decline. Mild Behavioral Impairment (MBI) represents late-life behavioral changes preceding or accompanying neurodegenerative processes. This study aimed to translate, culturally adapt, and psychometrically validate the Persian version of the Mild Behavioral Impairment Checklist (MBI-C) in older Iranian adults.
View Article and Find Full Text PDFBackground: Subjective cognitive decline (SCD) is known as the intermediate stage between normal cognitive aging and mild cognitive impairment (MCI). Although elderly with SCD usually perform close to normal in standardized tests, the detailed function of attention networks in this group has not been studied yet.
Aims: The purpose of this study was to investigate the performance of attention networks, as a possible indicator of cognitive disorder, in older individuals with subjective memory complaint and MCI.
Dement Geriatr Cogn Dis Extra
March 2021
Introduction: The Montreal Cognitive Assessment (MoCA) is a cognitive screening test widely used in clinical practice and suited for the detection of Mild Cognitive Impairment (MCI). The aims were to evaluate the psychometric properties of the Persian MoCA as a screening test for mild cognitive dysfunction in Iranian older adults and to assess its accuracy as a screening test for MCI and mild Alzheimer disease (AD).
Method: One hundred twenty elderly with a mean age of 73.
Objectives: Early detection of mild cognitive impairment (MCI) is necessary to prevent irreversible brain damage caused by incipient Alzheimer's disease. It has been showing that amnestic MCI (a-MCI) subjects exhibit subtle deficits in executive function that can be tested using saccade eye movements. Eye-tracking technology is a sensitive method to measure cognitive impairments in dementia and MCI.
View Article and Find Full Text PDFMild cognitive impairment (MCI) is an intermediate state between normal cognition and early dementia and is not considered as a typical outcome of brain aging. It has been estimated that 10% to 20% of individuals above 65 years of age will be diagnosed as having MCI. The increased rate of dementia and the importance of early detection of its forerunners have encouraged researchers to focus on detecting MCI and modifiable risk factors with the hope of developing better ways of managing dementia and its consequences.
View Article and Find Full Text PDFBackground: Mild Cognitive Impairment (MCI) has been considered as a prodromal stage of Alzheimer disease (AD). Subtle changes in specific aspects of executive function like inhibitory control have been found in MCI.
Aims: We examined attentional and inhibitory control with the aim to distinguish between amnestic MCI patients and healthy controls.